UPDATE 1-Anacor extends drug development deal with GlaxosSmithKline

* Says to get $5 mln upfront payment, additional $11.3 mlnproceeds by 2012 end * Says deal gives GSK access to tuberculosis, malariaprograms * Says gives GSK option to extend rights over one bacterialenzyme …